BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1246 related articles for article (PubMed ID: 18712836)

  • 1. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
    Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
    J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus DNA detection in women with primary abnormal cytology of the cervix: prevalence and distribution of HPV genotypes.
    Beerens E; Van Renterghem L; Praet M; Sturtewagen Y; Weyers S; Temmerman M; Depypere H; Claeys P; Cuvelier CA
    Cytopathology; 2005 Aug; 16(4):199-205. PubMed ID: 16048506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.
    Agarossi A; Ferrazzi E; Parazzini F; Perno CF; Ghisoni L
    J Med Virol; 2009 Mar; 81(3):529-35. PubMed ID: 19152401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 7.5-year prospective study of longer than 18 months type-specific human papillomavirus persistence in a routine cytology-based cervical screening population of about 31,000 women in West Germany.
    Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R; Hildenbrand R
    Eur J Cancer Prev; 2009 Aug; 18(4):307-15. PubMed ID: 19436214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, evolution, and features of infection with human papillomavirus: a 15-year longitudinal study of routine screening of a women population in the north of Spain.
    de Oña M; Alvarez-Argüelles ME; Torrents M; Villa L; Rodriguez-Feijoo A; Palacio A; Boga JA; Tamargo A; Melón S
    J Med Virol; 2010 Apr; 82(4):597-604. PubMed ID: 20166173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union.
    Kulmala SM; Shabalova IP; Petrovitchev N; Syrjänen KJ; Gyllensten UB; Syrjänen SM;
    J Med Virol; 2007 Jun; 79(6):771-81. PubMed ID: 17457909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
    Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
    N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of combined cytology and human papillomavirus (HPV) genotyping with adjuvant DNA-cytometry in routine cervical screening: results from 31031 women from the Bonn-region in West Germany.
    Bollmann R; Bankfalvi A; Griefingholt H; Trosic A; Speich N; Schmitt C; Bollmann M
    Oncol Rep; 2005 May; 13(5):915-22. PubMed ID: 15809758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.
    Bao YP; Li N; Smith JS; Qiao YL
    Int J STD AIDS; 2008 Feb; 19(2):106-11. PubMed ID: 18334063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
    Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population-based study of vaginal human papillomavirus infection in hysterectomized women.
    Castle PE; Schiffman M; Bratti MC; Hildesheim A; Herrero R; Hutchinson ML; Rodriguez AC; Wacholder S; Sherman ME; Kendall H; Viscidi RP; Jeronimo J; Schussler JE; Burk RD
    J Infect Dis; 2004 Aug; 190(3):458-67. PubMed ID: 15243917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human papillomavirus types in women with cervical cancer in Haifa District].
    Siegler E; Lahat N; Shiner M; Mackuli L; Aroudi Y; Shapiro S; Auslander R; Lavie O
    Harefuah; 2011 Nov; 150(11):837-41, 876. PubMed ID: 22428203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of human papillomavirus genotypes in Bulgarian women with atypical cervical lesions examined by colposcopy].
    Kovachev S; Nacheva A
    Akush Ginekol (Sofiia); 2010; 49(4):25-31. PubMed ID: 20734638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia.
    Stevens MP; Garland SM; Tan JH; Quinn MA; Petersen RW; Tabrizi SN
    J Med Virol; 2009 Jul; 81(7):1283-91. PubMed ID: 19475612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type-specific human papillomavirus distribution in invasive cervical carcinomas in Paraguay. A study of 432 cases.
    Kasamatsu E; Cubilla AL; Alemany L; Chaux A; Tous S; Mendoza L; Paez M; Klaustermeier JE; Quint W; Lloveras B; de Sanjose S; Muñoz N; Bosch FX
    J Med Virol; 2012 Oct; 84(10):1628-35. PubMed ID: 22930512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.